← Leaderboards
Yagna Jarajapu
North Dakota State University
$2,748,503
Attributed
$2,748,503
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $457.6K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,748,503 · 1
By mechanism
R01$2,748,503 · 1
Top collaborators
No co-investigators on record.
Most similar at North Dakota State University
Same institution · by research overlap
- Takahisa Kanekiyo$19,312,429
Others in their field
Other Emerging Leaders on “Impairment”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$25,556,733
- Tharick Pascoal · University Of Pittsburgh At Pittsburgh$25,068,887
- Suzanne L Baker · University Of Pittsburgh At Pittsburgh$20,465,582
Research focus
ImpairmentPreventStem CellsElderlyReceptorAgingPharmacologyVascular DiseasesBlood VesselsFunctional DisorderRenin-Angiotensin SystemCd34 GeneMediatingPrevalenceBone MarrowPathway InteractionsPreventionBaseEarly InterventionDiabetic MouseNatural RegenerationDiabeticDiabetes MellitusGenetic
Grant awards (10)
Stem Cell-Derived Exosomes, MrgD and Vascular Cognitive Impairment in Aging$436,387
R01 · FY2025 · AG · contact PI
Stem Cell-Derived Exosomes, MrgD and Vascular Cognitive Impairment in Aging$435,143
R01 · FY2024 · AG · contact PI
Stem Cell-Derived Exosomes, MrgD and Vascular Cognitive Impairment in Aging$457,643
R01 · FY2023 · AG · contact PI
Targeting Mas Receptor for Diabetic Vascular Disease in Older Adults$253,750
R01 · FY2021 · AG · contact PI
Targeting Mas Receptor for Diabetic Vascular Disease in Older Adults$309,665
R01 · FY2020 · AG · contact PI
Targeting Mas Receptor for Diabetic Vascular Disease in Older Adults$284,665
R01 · FY2019 · AG · contact PI
Targeting ACE2/Angiotensin-(1-7)/Mas Axis in the Vascular Progenitor Cells for the Treatment of Cognitive Dysfunction in Diabetic Older Adults$50,000
R01 · FY2019 · AG · contact PI
Targeting Mas Receptor for Diabetic Vascular Disease in Older Adults$253,750
R01 · FY2018 · AG · contact PI
Targeting Mas Receptor for Diabetic Vascular Disease in Older Adults$50,000
R01 · FY2018 · AG · contact PI
Targeting Mas Receptor for Diabetic Vascular Disease in Older Adults$217,500
R01 · FY2017 · AG · contact PI